DEPYMED
Live / Applied — Fourth extension granted (statement of use) (as of 11 Jun 2025)
What this means for you
Not registered yet, but its 26 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97430271
- Mark type
- Stylized text
- Filed
- 26 May 2022
- Published for opposition
- 18 Apr 2023
- Attorney of record
- Kristen Mollnow Walsh
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of cancer, rare diseases, lung disorders and respiratory diseases, cardiovascular diseases, and other metabolic, inflammatory and central nervous system or neurodegenerative diseases
- Class 042 — Scientific and technological services: Pharmaceutical research and development; conducting early evaluations in the field of new pharmaceuticals
Owner
- DepYmed Inc., Farmingdale, NY, US
- DepYmed Inc., Farmingdale, NY, US
Prosecution history
- 04 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jun 2025 — SOU EXTENSION 4 GRANTED
- 11 Jun 2025 — SOU EXTENSION 4 FILED
- 11 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Oct 2024 — SOU EXTENSION 3 GRANTED
- 18 Oct 2024 — SOU EXTENSION 3 FILED
- 18 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2024 — SOU EXTENSION 2 GRANTED
- 29 Apr 2024 — SOU EXTENSION 2 FILED
- 29 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED